According to the latest market intelligence report published by Future Market Insights (FMI), the global IV bag market is estimated to reach USD 2.5 billion in 2026, following the 2025 historical assessment period, and is projected to reach USD 3.8 billion by 2036. The market is forecast to expand at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2036, supported by rising demand for intravenous therapies, parenteral nutrition, and hydration for patients with chronic conditions. The report also highlights growing interest in ready-to-administer formulations and alternative medical-grade polymer materials.

Market Size & Growth Forecasts

• 2025 Baseline Value: Not specified in the publicly accessible report summary.
• 2026 Estimated Market Size: USD 2.5 billion.
• 2036 Projected Value: USD 3.8 billion.
• Growth Rate: 6.1% CAGR from 2026 to 2036.
• Incremental Growth Opportunity: USD 1.3 billion between 2026 and 2036, based on the reported rounded market values.

The forecast reflects the continued need for dependable fluid-delivery systems across hospitals and other healthcare settings. Demand is supported by hydration, medication delivery, and nutritional therapies, alongside efforts to improve medication preparation and administration workflows.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-3580

Key Market Segments

By Chamber Type and Material

• Single-Chamber IV Bags: Account for 58% of market share in 2026, supported by high-volume use in fluid resuscitation, saline and dextrose delivery, and routine hospital therapies.
• PVC-Based Materials: Hold a 46% share in 2026, reflecting established manufacturing processes and cost efficiency.
• Alternative Materials: Non-DEHP PVC and polyolefin-based films are gaining attention as manufacturers address drug compatibility and plasticizer-related safety requirements. FMI notes that advanced polymer materials can cost approximately 15–20% more than traditional PVC.

By Application

• Intravenous Therapies: Represent 60% of market share in 2026, reflecting widespread use for hydration, infection treatment, and medication delivery.
• Parenteral Nutrition: Remains an important application, with demand for packaging that protects sensitive formulations and supports appropriate storage and administration.
• Ready-to-Administer (RTA) IV Bags: The report states that these formats can reduce medication errors by approximately 30%, supporting hospital interest in premixed solutions.

By Country / Region

• India: Projected to grow at a 7.2% CAGR through 2036, supported by expanding hospital infrastructure, domestic medical-device manufacturing, and greater demand for fluid therapy.
• China: Forecast to expand at a 7.0% CAGR, driven by an aging population, critical-care capacity expansion, and modernization of medical consumables.
• United States: Expected to record a 5.0% CAGR, supported by demand for parenteral nutrition, chemotherapy, and premixed solutions.
• Germany: Projected to grow at a 4.6% CAGR, with demand shaped by healthcare infrastructure and non-PVC material adoption.
• Japan: Expected to register a 3.3% CAGR, supported by geriatric care, home-based treatment, and nutritional support.

Major Market Trends & Drivers

• Growth in Chronic Disease Management: Greater need for hydration, intravenous medication, and parenteral nutrition supports demand for dependable IV containers.
• Material Transition and Patient Safety: Manufacturers are evaluating non-DEHP PVC and polyolefin-based films to address drug compatibility and plasticizer concerns. These materials may require different sealing technologies and additional equipment investment.
• Premixed and Home-Based Therapies: Ready-to-administer formats, home infusion, and portable IV systems are influencing product design. Multi-chamber bags also support formulations in which ingredients need to remain separated until administration.

Competitive Landscape

The market features established medical-device and healthcare suppliers competing through manufacturing scale, material expertise, product development, and supply-chain integration. According to FMI, manufacturers are increasingly focused on vertical integration from resin extrusion to final filling, developing films with improved drug compatibility, and collaborating with pharmaceutical companies on premixed drug solutions. Baxter is reported to hold a 14% market share.

Key Companies Profiled Include: Baxter, B. Braun Medical, ICU Medical, Inc., Fresenius Kabi Group, Hospira, Terumo Corporation, Wipak Group Management, Poly Medicure, Renolit, and Mountainside Medical Equipment.

>> Access detailed market insights: https://www.futuremarketinsights.com/reports/iv-bag-market

Analyst Perspective / Insight

FMI’s published analysis indicates that future competitiveness will depend on combining reliable fluid-delivery performance with drug-compatible materials and efficient manufacturing. Investment in alternative polymers, premixed formulations, and integrated production capabilities may help suppliers address evolving hospital procurement needs

Shipping Container Market: https://www.futuremarketinsights.com/reports/shipping-container-market

Smart Packaging Market: https://www.futuremarketinsights.com/reports/smart-packaging-market

Stainless Steel Water Bottles Market: https://www.futuremarketinsights.com/reports/stainless-steel-water-bottles-market

MEDIA CONTACT

Contact Person: Media Relations Team
Designation: Corporate Communications
Email: sales@futuremarketinsights.com
Phone: +1-347-918-3531
Website: https://www.futuremarketinsights.com/

ABOUT FUTURE MARKET INSIGHTS

Future Market Insights, Inc. (FMI) is an ESOMAR-certified market research and consulting firm headquartered in Delaware, USA, with offices in the United Kingdom, the United Arab Emirates, and India. FMI delivers syndicated and custom research across food and beverage, healthcare, chemicals, technology, packaging, consumer goods, and industrial sectors. Its research helps organizations assess market opportunities, understand industry developments, and make informed strategic decisions.